COST-EFFECTIVENESS OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AS ADJUNCTIVE THERAPY IN CANCER PATIENTS WITH ESTABLISHED FEBRILE NEUTROPENIA

被引：0
|
作者：
Tong, W. X. [1 ]
Wang, X. J. [1 ]
Chan, A. [1 ]
机构：
[1] Natl Univ Singapore, Singapore, Singapore
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.08.146
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN25
引用
收藏
页码：A912 / A912
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Granulocyte Colony-Stimulating Factor Prophylaxis for Febrile Neutropenia in Breast Cancer in the United Kingdom
    Whyte, Sophie
    Cooper, Katy L.
    Stevenson, Matt D.
    Madan, Jason
    Akehurst, Ron
    [J]. VALUE IN HEALTH, 2011, 14 (04) : 465 - 474
  • [2] Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
    Matti S. Aapro
    Stephen Chaplin
    Paul Cornes
    Sebastian Howe
    Hartmut Link
    Natalia Koptelova
    Andrea Mehl
    Mario Di Palma
    Bridgette Kanz Schroader
    Robert Terkola
    [J]. Supportive Care in Cancer, 2023, 31
  • [3] Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
    Aapro, Matti S.
    Chaplin, Stephen
    Cornes, Paul
    Howe, Sebastian
    Link, Hartmut
    Koptelova, Natalia
    Mehl, Andrea
    Di Palma, Mario
    Schroader, Bridgette Kanz
    Terkola, Robert
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (10)
  • [4] Granulocyte-macrophage colony-stimulating factor in established febrile neutropenia
    Mitchell, PLR
    Pinkerton, CR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 3002 - 3002
  • [5] Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D
    Lee, Esther K.
    Wong, William W. L.
    Trudeau, Maureen E.
    Chan, Kelvin K. W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 169 - 180
  • [6] Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D
    Esther K. Lee
    William W. L. Wong
    Maureen E. Trudeau
    Kelvin K. W. Chan
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 169 - 180
  • [7] Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors
    Laali, Elahe
    Fazli, Jinous
    Sadighi, Sanambar
    Mohammadi, Mehdi
    Gholami, Kheirollah
    Jahangard-Rafsanjani, Zahra
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 428 - 433
  • [8] Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models
    Fust, Kelly
    Parthan, Anju
    Maschio, Michael
    Gu, Qing
    Li, Xiaoyan
    Lyman, Gary H.
    Tzivelekis, Spiros
    Villa, Guillermo
    Weinstein, Milton C.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 39 - 52
  • [9] Granulocyte colony-stimulating factor in established febrile neutropenia: A randomized study of pediatric patients
    Mitchell, PLR
    Morland, B
    Stevens, MCG
    Dick, G
    Easlea, D
    Meyer, LC
    Pinkerton, CR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1163 - 1170
  • [10] Preparation of immunotoxin using granulocyte colony-stimulating factor (G-CSF), for cancer therapy
    Niknia, Soudabe
    Ghadam, Parinaz
    Khaje, Khosro
    Zeinoddini, Mehdi
    [J]. CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S45 - S45
12345